TrialNaunyn-Schmiedeberg's archives of pharmacology2024

Evaluation of the effect of empagliflozin on prevention of atrial fibrillation after coronary artery bypass grafting: a double-blind, randomized, placebo-controlled trial.

Batool Zarei et al.PubMed ↗Publisher ↗

No numbers read from the abstract.